Source: International Congress 2016 – Pharmacological management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Claus Vogelmeier (Marburg, Germany), Claus Vogelmeier, Leonardo M. Fabbri, Susan Bell, Kay Tetzlaff, Helgo Magnussen, Henrik Watz. Identification of factors associated with exacerbation risk in severe COPD: Multivariate analysis of the WISDOM study. Eur Respir J 2016; 48: Suppl. 60, 302

Member's Comments

No comment yet.

Related content which might interest you: Risk factors of poor outcomes after admission for a COPD exacerbations. Multivariate logistic predictive models Source: International Congress 2015 – COPD: interesting notes Year: 2015 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Cardiovascular risk assessment in COPD patients with severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Predictive factors of 90-days post-discharge COPD acute exacerbation’s recurrence Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Identifying factors associated with severe asthma exacerbations: a retrospective study Source: Eur Respir J 2007; 30: Suppl. 51, 626s Year: 2007 Key factors associated with readmission in COPD patients Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 The frequency of COPD exacerbations is related to the comorbidity profile Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Recurrent exacerbation of asthma: Characteristics of the patients and risk factors Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD) Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Risk factors for severe exacerbations in asthma Source: Eur Respir J 2002; 20: Suppl. 38, 199s Year: 2002 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016